Publication

  • Home
  • Publications
  • Actions of Novel Angiotensin Receptor Blocking Drugs, Bisartans, Relevant for COVID-19 Therapy: Biased Agonism at Angiotensin Receptors and the Beneficial Effects of Neprilysin in the Renin Angiotensin System

Quick Links

View publications by R&D field

Search

Research Project, Scientists etc

Search

Actions of Novel Angiotensin Receptor Blocking Drugs, Bisartans, Relevant for COVID-19 Therapy: Biased Agonism at Angiotensin Receptors and the Beneficial Effects of Neprilysin in the Renin Angiotensin System

Moore, G.J.; Ridgway, H.; Kelaidonis, K.; Chasapis, C.T.; Ligielli, I.; Mavromoustakos, T.; Bojarska, J.; Matsoukas, J.M.

Journal: MOLECULES Year: 2022 Volume: 27 Issue: Pages: art. no. 4854
DΟΙ: https://doi.org/10.3390/molecules27154854
Research Fields: